Arbutus Biopharma Corporation
DE ˙ DB ˙ CA03879J1003
3,73 € ↑0,06 (1,63%)
2026-06-04
DEL PRIS
SecurityDE:I9DN / Arbutus Biopharma Corporation
InstitutionJane Street Group, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Jane Street Group, Llc ownership in I9DN / Arbutus Biopharma Corporation

On May 12, 2026 - Jane Street Group, Llc filed a 13F-HR form disclosing ownership of 0 shares of Arbutus Biopharma Corporation (DE:I9DN) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 83,933 shares of Arbutus Biopharma Corporation. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Jane Street Group, Llc has a history of taking positions in derivatives of the underlying security (I9DN) in the form of stock options. The firm currently holds call options representing 33,000 of underlying shares valued at $148,500 USD and put options representing 25,500 of underlying shares valued at $114,750 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:I9DN / Arbutus Biopharma Corporation Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 0 -83,933 -100.00 0 -100.00
2026-02-12 2025-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 83,933 -216,522 -72.06 404 -70.45 0.0001
2025-11-14 2025-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 300,455 77,659 34.86 1,364 98.26 0.0002
2025-08-14 2025-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 222,796 -57,964 -20.65 688 -29.72 0.0001
2025-05-19 2025-03-31 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 280,760 280,760 980 0.0002
2025-05-14 2025-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 280,760 280,760 980 0.0002
2025-02-14 2024-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 0 -66,910 -100.00 0 -100.00
2024-11-15 2024-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 66,910 -136,488 -67.10 258 -59.08 0.0001
2024-08-15 2024-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 203,398 159,279 361.02 628 455.75 0.0001
2024-05-16 2024-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 44,119 -52,390 -54.29 114 -53.11 0.0000
2024-02-15 2023-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 96,509 96,509 241 0.0001
2023-08-14 2023-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 0 -136,288 -100.00 0 -100.00
2023-05-16 2023-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 136,288 29,742 27.91 413 66.13 0.0002
2023-02-15 2022-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 106,546 87,677 464.66 248 588.89 0.0001
2022-11-15 2022-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 18,869 -23,732 -55.71 36 -68.70 0.0000
2022-08-16 2022-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 42,601 -39,213 -47.93 115 -52.87 0.0000
2022-05-17 2022-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 81,814 -271,066 -76.82 244 -82.23 0.0001
2022-02-15 2021-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 352,880 130,119 58.41 1,373 43.62 0.0005
2021-11-16 2021-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 222,761 201,526 949.03 956 1,370.77 0.0003
2021-08-16 2021-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 21,235 -32,127 -60.21 65 -63.28 0.0000
2021-05-18 2021-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 53,362 14,298 36.60 177 27.34 0.0001
2021-02-17 2020-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 39,064 22,239 132.18 139 162.26 0.0001
2020-11-17 2020-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 16,825 -89,356 -84.15 53 -72.68 0.0000
2020-08-17 2020-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 106,181 33,256 45.60 194 165.75 0.0001
2020-05-15 2020-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 72,925 72,925 73 0.0001
2019-11-14 2019-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 0 -167,188 -100.00 0 -100.00
2019-08-15 2019-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 167,188 167,188 348 0.0006
2018-02-15 2017-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 0 -10,983 -100.00 0 -100.00
2017-11-14 2017-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 10,983 10,983 68 0.0002
2016-02-16 2015-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 0 -25,374 -100.00 0 -100.00
2015-11-16 2015-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 25,374 25,374 155 0.0010
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F ARBUTUS BIOPHARMA COM Call 33,000 223.53 148 202.04 n/a n/a n/a
2026-02-12 2025-12-31 13F ARBUTUS BIOPHARMA COM Call 10,200 -57.50 49 -54.63 n/a n/a n/a
2025-11-14 2025-09-30 13F ARBUTUS BIOPHARMA COM Call 24,000 -13.36 109 27.06 n/a n/a n/a
2025-08-14 2025-06-30 13F ARBUTUS BIOPHARMA COM Call 27,700 -50.45 86 -56.41 n/a n/a n/a
2025-05-19 2025-03-31 13F/A ARBUTUS BIOPHARMA COM Call 55,900 195 n/a n/a n/a
2025-05-14 2025-03-31 13F ARBUTUS BIOPHARMA COM Call 55,900 195 n/a n/a n/a
2023-05-15 2023-03-31 13F ARBUTUS BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-15 2022-12-31 13F ARBUTUS BIOPHARMA COM Call 25,500 0.00 59 20.41 n/a n/a n/a
2022-11-15 2022-09-30 13F ARBUTUS BIOPHARMA COM Call 25,500 -22.96 49 -45.56 n/a n/a n/a
2022-08-16 2022-06-30 13F ARBUTUS BIOPHARMA COM Call 33,100 -73.98 90 -76.25 n/a n/a n/a
2022-05-17 2022-03-31 13F ARBUTUS BIOPHARMA COM Call 127,200 -44.41 379 -57.42 n/a n/a n/a
2022-02-15 2021-12-31 13F ARBUTUS BIOPHARMA COM Call 228,800 341.70 890 300.90 n/a n/a n/a
2021-11-16 2021-09-30 13F ARBUTUS BIOPHARMA COM Call 51,800 222 n/a n/a n/a
2021-08-16 2021-06-30 13F ARBUTUS BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-18 2021-03-31 13F ARBUTUS BIOPHARMA COM Call 60,100 -60.64 200 -63.10 n/a n/a n/a
2021-02-17 2020-12-31 13F ARBUTUS BIOPHARMA COM Call 152,700 542 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F ARBUTUS BIOPHARMA COM Put 25,500 -50.10 115 -53.47 n/a n/a n/a
2026-02-12 2025-12-31 13F ARBUTUS BIOPHARMA COM Put 51,100 246 n/a n/a n/a
2025-08-14 2025-06-30 13F ARBUTUS BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-19 2025-03-31 13F/A ARBUTUS BIOPHARMA COM Put 17,800 62 n/a n/a n/a
2025-05-14 2025-03-31 13F ARBUTUS BIOPHARMA COM Put 17,800 62 n/a n/a n/a
2022-11-14 2022-09-30 13F ARBUTUS BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-16 2022-06-30 13F ARBUTUS BIOPHARMA COM Put 38,000 -83.16 103 -84.70 n/a n/a n/a
2022-05-17 2022-03-31 13F ARBUTUS BIOPHARMA COM Put 225,700 -14.73 673 -34.66 n/a n/a n/a
2022-02-15 2021-12-31 13F ARBUTUS BIOPHARMA COM Put 264,700 42.08 1,030 28.91 n/a n/a n/a
2021-11-16 2021-09-30 13F ARBUTUS BIOPHARMA COM Put 186,300 339.39 799 524.22 n/a n/a n/a
2021-08-16 2021-06-30 13F ARBUTUS BIOPHARMA COM Put 42,400 -9.59 128 -17.95 n/a n/a n/a
2021-05-18 2021-03-31 13F ARBUTUS BIOPHARMA COM Put 46,900 -42.59 156 -46.21 n/a n/a n/a
2021-02-17 2020-12-31 13F ARBUTUS BIOPHARMA COM Put 81,700 290 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.